ONCO Onconetix, Inc.

Nasdaq onconetix.gcs-web.com


$ 3.31 $ -0.03 (-0.89 %)    

Friday, 17-Oct-2025 12:51:37 EDT
QQQ $ 601.05 $ 3.68 (0.62 %)
DIA $ 460.48 $ 1.10 (0.24 %)
SPY $ 661.36 $ 1.89 (0.29 %)
TLT $ 91.13 $ -0.10 (-0.11 %)
GLD $ 386.93 $ -10.32 (-2.59 %)
$ 3.47
$ 3.36
$ 3.30 x 300
$ 3.35 x 101
$ 3.32 - $ 3.33
$ 2.45 - $ 552.50
36,405
na
1.97M
$ 2.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 06-12-2025 03-31-2025 10-Q
3 06-02-2025 12-31-2024 10-K
4 12-10-2024 09-30-2024 10-Q
5 08-29-2024 06-30-2024 10-Q
6 05-20-2024 03-31-2024 10-Q
7 04-11-2024 12-31-2023 10-K
8 11-17-2023 09-30-2023 10-Q
9 10-20-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-09-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

Core News & Articles

Onconetix, Inc. (NASDAQ:ONCO) ("Onconetix" or the "Company") a commercial stage biotechnology company focused o...

Core News & Articles

Onconetix (NASDAQ:ONCO) reported quarterly losses of $(4.76) per share. This is a 99.78 percent increase over losses of $(2.19 ...

Core News & Articles

Pursuant to the Merger Agreement, Onconetix will acquire all of the issued and outstanding equity interests of Ocuvex and, in c...

Core News & Articles

Onconetix, Inc. (NASDAQ:ONCO) ("Onconetix" or the "Company"), a commercial-stage biotechnology company focused ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION